Pharmafile Logo
Pharmafocus logo
Advanced Search
richard-francis-big-image_0

Sandoz CEO Richard Francis to step down

March 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …

Appointment
images

Roche scores two EU approvals in haemophilia and rare autoimmune disease

March 15, 2019
Medical Communications EC, EU, Europe, Roche, haemophilia, rare diseases

The European Commission (EC) has approved Roche’s haemophilia treatment Hemlibra (emicizumab). The approval comes as the EC approved Roche’s MabThera …

News
merckwindow_web

MSD’s Keytruda/chemo combo nabs EU approval in first-line metastatic squamous lung cancer

March 15, 2019
Medical Communications, Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

MSD’s anti-PD-L1 therapy Keytruda (pembrolizumab) has been awarded marketing authorisation in Europe for the first-line treatment of adult patients with …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Acadia Pharmaceuticals, FDA, Sandoz, brexit, genomics, pharma, pharmacovigilance, top 10

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …

News
ianread

Pfizer CEO Ian Read’s pay packet cut from $27.9m to $19.5m

March 15, 2019
Medical Communications CEO, Ian Read, Pfizer, compensation, pay packet, salary

Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this …

News
roche_dark_0

Roche and Chugai’s Hemlibra scoops up EU approval in the prevention of severe haemophilia A without factor VIII inhibitors

March 14, 2019
Sales and Marketing Chugai, Hemlibra, Roche, haemophilia, pharma

Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a …

News
celgene_building

Celgene’s Abraxane combo flops in phase 3 cancer trials

March 14, 2019
Research and Development Abraxane, Celgene, clinical trials, pharma, trials

Celgene’s Abraxane, in combination gemcitabine, has failed to meet its primary endpoint in a pivotal Phase 3 trial of patients …

News
ent-cholesterol_molecule_spacefill

New class of drugs offer alternative to statins

March 14, 2019
Research and Development cholesterol, health, imperial college london, research, statins

A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study …

News
richard-francis-big-image

Sandoz CEO Richard Francis to step down

March 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, Sandoz, appointment, pharma

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …

News

Califonia court rules J&J must pay woman with mesothelioma $29 million

March 14, 2019
Medical Communications, Sales and Marketing

A California jury has ordered American healthcare conglomerate Johnson & Johnson to pay more than $29 million to a woman …

News
norman_sharpless_official_photo

National Cancer Institute Director Ned Sharpless to become interim FDA Commissioner

March 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Ned Sharpless, Scott Gottlieb, appointment, pharma

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of …

News
janssen_latest_logo_on_sign_closer

Janssen’s ulcerative colitis treatment shows positive results in phase 3 trials

March 13, 2019
Manufacturing and Production, Research and Development Jansenn, Stelara, phase 3 trials, ulcerative colitis

Janssen’s ulcerative colitis treatment, Stelara (ustekinumab subcutaneous) has shown positive results as maintenance therapy in phase 3 trials. The study …

News
lilly_building_with_american_flag_web

Lilly’s Cyramza hits Phase 3 endpoint in first-line metastatic lung cancer treatment

March 13, 2019
Research and Development Cancer, Eli Lilly, cyramza, lung cancer, pharma

Eli Lilly’s vascular endothelial growth factor (VEGF) Receptor 2 antagonist Cyramza (ramucirumab) has succeeded in hitting its primary endpoint at …

News
28246711066_52e38bc591_z

Healthcare industry could take up to five years to stabilise after no-deal Brexit

March 13, 2019
Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …

News
5204602349_c87b204860_z

FDA approve valsartan generic after shortages of supply

March 13, 2019
Manufacturing and Production, Research and Development FDA, blood pressure drugs, cardiovascular, generic, valsartan

The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply …

News
tt-img-leadership-jennifer

Innate Pharma hires Jennifer Butlers to lead commercialisation of leukaemia drug Lumoxiti

March 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French company Innate Pharma have announced the appointment of Jennifer Butler to the position of Executive Vice President and General …

Appointment
dupixentpackage

FDA expands Dupixent indication to include moderate-to-severe atopic dermatitis in adolescent patients

March 12, 2019
Manufacturing and Production, Sales and Marketing Dupixent, Regeneron, Sanofi, pharma

Partners Sanofi and Regeneron have both revealed that their jointly developed drug Dupixent (dupilumab) has been authorised by the FDA …

News
facilities_lg06

Dr Reddy’s demand more than $70 million from Indivior over generic Suboxone Film

March 12, 2019
Manufacturing and Production Dr Reddy's, Suboxone Film, court, indivior, opioid addiction

Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales …

News
janssen_latest_logo_on_sign

NICE recommends Janssen’s Darzalex myeloma combo

March 12, 2019
Manufacturing and Production Janssen, NICE, Velcade, darzalex, myeloma

Britain’s cost effectiveness body NICE have recommended Janssen Pharmaceutical’s Darzalex in combination with Velcade and dexamethasone (DVd), for use within …

News

FDA approves Pfizer’s Herceptin biosimilar Trazimera

March 12, 2019
Manufacturing and Production, Sales and Marketing Humira, Pfizer, Trazimera, biosimilar, pharma

Patients in the US will now be able to access another biosimilar version of Herceptin (trastuzumab) with the FDA approval …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026